| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/06/2010 | EP2139916A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 01/06/2010 | EP2139915A2 Glycan modified soluble receptors and binding proteins and their use |
| 01/06/2010 | EP2139914A1 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 01/06/2010 | EP2139509A2 Treatment of autoimmune disorders |
| 01/06/2010 | EP2139501A1 Use of francisella tularensis for prevention and treatment of allergic airway disorders |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1452539B1 Antifreeze proteins originating in fish |
| 01/06/2010 | EP1432722B1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/06/2010 | EP1404877B1 Assays for preimplantation factor and preimplantation factor peptides |
| 01/06/2010 | EP1404360B1 Monodisperse mixtures of calcitonin drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 01/06/2010 | EP1355944B1 Rtvp based compositions and methods for the treatment of prostate cancer |
| 01/06/2010 | EP1309727B1 Method for functional mapping of the gene network of Alzheimer's disease |
| 01/06/2010 | EP1282717B1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP1062243B1 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments |
| 01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/06/2010 | CN101622274A Transferrin fusion protein libraries |
| 01/06/2010 | CN101622273A Methods of treating, diagnosing or detecting cancers associated with LIV-1 overexpression |
| 01/06/2010 | CN101622272A Modified flagellin improved toll-like receptor 5 stimulating activity |
| 01/06/2010 | CN101619102A Preparation and application of chlamys farreri peptidoglycan recognition protein (Cf-PGRP) with sterilizing activity |
| 01/06/2010 | CN101619101A Rhinolophus ferrumequinum leptin protein and cDNA sequence thereof |
| 01/06/2010 | CN101619100A Human recombinant chemerin protein, recombinant vector, transformant and prepration method thereof |
| 01/06/2010 | CN101619099A Method for extracting rapeseed protein by reverse micelle |
| 01/06/2010 | CN101619098A Backward extraction method for extracting rapeseed protein by reverse micelle |
| 01/06/2010 | CN101619097A Method for preparing oat ice structural protein with thermal stability |
| 01/06/2010 | CN101619096A Protein related to plant stress-tolerance, coding gene and application thereof |
| 01/06/2010 | CN101619095A Preparation method of soybean polysaccharide protein in soybean dregs |
| 01/06/2010 | CN101619094A Rice final height-related protein, coding gene thereof and application thereof |
| 01/06/2010 | CN100577804C Novel mutant allergens |
| 01/06/2010 | CN100577803C transgenic animal for expressing Alzheimer tau protein |
| 01/06/2010 | CN100577686C Oligomeric peptides and their use for the treatment of HIV infections |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577684C Protein relative with DNA target practice efficiency of chestnut epidemic disease bacterium, encoding gene and application of the same |
| 01/06/2010 | CN100577683C Infectious cDNA of an approved vaccine strain of measles virus, use for the same used as immunogenic compositions |
| 01/06/2010 | CN100577205C Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions prepared therefrom |
| 01/05/2010 | US7642433 Plants and seeds of hybrid corn variety CH187789 |
| 01/05/2010 | US7642346 Using expression vector comprising plant promoter elements as tool for transfer and expression of heterologous sequences in plants; bioreactors |
| 01/05/2010 | US7642345 Polynucleotides encoding human cytokine receptor |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642340 tumor necrosis factor variants covalently attached to polyethylene glycol |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7642242 Glial Cell line-derived Neurotrophic Factor Receptor; neuronal disorders, Parkinson's, Alzheimers or neuronal injury |
| 01/05/2010 | US7642240 Bioconjugates comprising sulfated polysaccharides and their uses |
| 01/05/2010 | US7642237 Growth/differentiation factor of the TGF-β family |
| 01/05/2010 | US7642236 Recombinant lubricin molecules and uses thereof |
| 01/05/2010 | US7642233 Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein |
| 01/05/2010 | US7642231 Neo-tryptophan |
| 01/05/2010 | US7642228 Method for making heteromultimeric polypeptides |
| 01/05/2010 | US7642083 Generation of hydroquinone and derivatives; obtain quinic acid, oxidize to 3,4,5-trihydroxycyclohexanone, convert 3,4,5-trihydroxycyclohexanone to hydroquinone |
| 01/05/2010 | US7642072 Optimized interferon-beta gene |
| 01/05/2010 | US7642070 Tumor suppressor gene |
| 01/05/2010 | US7642069 Process for the intracellular over-production of streptokinase using genetically engineered strain of E. coli |
| 01/05/2010 | US7642061 Using primate t-cell leukemia viruses (PTLV) envelopes to target antitumor therapeutic to cells expressing glucose transport proteins (GLUT-1) |
| 01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 01/05/2010 | US7642052 Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms |
| 01/05/2010 | US7642051 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 01/05/2010 | US7642044 Trimerising module |
| 01/05/2010 | US7641918 Plasma cryoprecipitate substantially free of plasminogen |
| 01/05/2010 | US7641910 Amino acid sequence or immunogenic fragment of at least 15 contiguous amino acid sequence when administered to a subject induce antibody or T-cell mediated immune response that recognizes polypeptide |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641905 Methods of inducing an immune response |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
| 01/05/2010 | US7641896 Adjuvant viral particle |
| 01/05/2010 | US7641895 Peptides for active anti-cytokine immunization |
| 01/05/2010 | US7641894 Stimulating neutrophil function to treat inflammatory bowel disease |
| 01/05/2010 | CA2592555C Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2381995C Method for the production of proteinaceous substances |
| 01/05/2010 | CA2369884C Transiently immortalized cells for use in gene therapy |
| 01/05/2010 | CA2346998C Baculovirus expression system |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2300480C Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 01/05/2010 | CA2290717C Nucleic acid binding proteins |
| 01/05/2010 | CA2281877C Psca: prostate stem cell antigen |
| 01/05/2010 | CA2260759C Recombinant swinepox virus |
| 01/05/2010 | CA2234119C Improved barstar gene |
| 01/05/2010 | CA2202496C Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/05/2010 | CA2184681C Process for preparing substituted n-ethylglycine derivatives |
| 01/05/2010 | CA2182810C Bacteriocin from micrococcus varians |
| 01/05/2010 | CA2164835C Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/05/2010 | CA2143296C New bacillus thuringiensis strains and their insecticidal proteins |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/03/2010 | CA2653866A1 Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
| 12/31/2009 | US20090328254 Novel vip3 toxins and methods of use |
| 12/31/2009 | US20090328252 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 12/31/2009 | US20090328250 Expression of tgf-beta in plastids |
| 12/31/2009 | US20090328247 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants |
| 12/31/2009 | US20090327170 Methods of Clustering Gene and Protein Sequences |
| 12/31/2009 | US20090326204 Interferon-like protein zcyto21 |
| 12/31/2009 | US20090326201 Affinity Adsorbents for Fibrinogen |
| 12/31/2009 | US20090326200 Altered ospa of borrelia burgdorferi |
| 12/31/2009 | US20090326199 IFBM's to Promote the Specific Attachment of Target Analytes to the Surface of Orthopedic Implants |
| 12/31/2009 | US20090326198 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins |
| 12/31/2009 | US20090326196 Proteins Containing a Fluorinated Amino Acid, and Methods of Using Same |
| 12/31/2009 | US20090326193 Stabilizing alkylglycoside compositions and methods thereof |
| 12/31/2009 | US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/31/2009 | US20090325886 Wt1 modified peptide |
| 12/31/2009 | US20090325883 Peptides Which Interact with Anti-Apoptotic Members of the BCL-2 Protein Family, and Uses |